Global Health Ltd (MEDANTA)
₹1,371.00
Mkt cap
₹36,862 Cr
P/E ratio
66.20
P/B
9.33
Div yield
0.04%
ROE
15.20%
ROCE
17.10%
EPS (TTM)
₹20.71
Book value
₹147
52W range
961–1,427
Sector
Healthcare
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. [1]
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−3.94% from high₹1,371
₹961+42.65% from low₹1,427
Current
₹1,371.00
Prev close
₹1,371.00
Day
0.00%
Price performance
1D
0.00%
1W
+2.97%
1M
+4.47%
3M
+24.01%
6M
+27.45%
1Y
+1.93%
YTD
+12.64%
Financials
FRevenue, profit & margin
P/E ratio
66.2×
MEDANTA is 38% above the sector median of 48.1×
MEDANTA66.2×
Sector median48.1×
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 707 | 780 | 844 | 836 | 809 | 861 | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | |
| Expenses | 540 | 595 | 631 | 620 | 629 | 675 | 728 | 706 | 707 | 784 | 868 | 904 | 915 | |
| Operating Profit | 167 | 184 | 213 | 216 | 179 | 186 | 228 | 238 | 225 | 247 | 231 | 217 | 244 | |
| OPM % | 24% | 24% | 25% | 26% | 22% | 22% | 24% | 25% | 24% | 24% | 21% | 19% | 21% | |
| Other Income | 25 | 15 | 21 | 18 | 27 | 22 | 18 | 16 | -27 | 20 | 36 | -15 | 37 | |
| Interest | 20 | 18 | 20 | 18 | 18 | 18 | 16 | 16 | 15 | 14 | 17 | 22 | 27 | |
| Depreciation | 38 | 40 | 43 | 44 | 45 | 47 | 49 | 48 | 49 | 45 | 50 | 61 | 67 | |
| Profit before tax | 133 | 141 | 171 | 172 | 143 | 144 | 181 | 189 | 133 | 208 | 200 | 120 | 187 | |
| Tax % | 24% | 28% | 27% | 28% | 11% | 26% | 28% | 24% | 24% | 24% | 21% | 21% | 24% | |
| Net Profit | 101 | 102 | 125 | 124 | 127 | 106 | 131 | 143 | 101 | 159 | 158 | 95 | 142 | |
| EPS in Rs | 3.77 | 3.80 | 4.66 | 4.61 | 4.74 | 3.96 | 4.87 | 5.32 | 3.78 | 5.92 | 5.89 | 3.54 | 5.36 | |
| Raw PDF |
Earnings
EResults dates & reactionsNext results
30 Jul '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.82% · closed higher next day 9 of last 14
| Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 10 Aug '23◦ | 9 Nov '23◦ | 8 Feb '24◦ | 17 May '24◦ | 8 Aug '24◦ | 14 Nov '24◦ | 4 Feb '25◦ | 15 May '25◦ | 7 Aug '25◦ | 7 Nov '25◦ | 4 Feb '26◦ | 14 May '26◦ |
| Earnings day | −1.79% | +5.01% | +0.85% | −1.20% | −3.44% | +0.83% | +10.73% | −3.39% | +7.25% | −5.42% | −1.34% | +2.52% |
| +1 day | −2.09% | +5.94% | +6.96% | −6.05% | −7.85% | +1.86% | +12.23% | −5.01% | +4.55% | −6.30% | +1.77% | +2.25% |
| +5 days | −0.17% | +4.32% | +14.04% | −13.93% | −5.77% | +2.82% | +4.67% | −1.88% | +1.22% | −3.97% | +2.30% | +2.16% |
| +15 days | +2.08% | +16.72% | +3.16% | −14.68% | −3.77% | +6.46% | +14.60% | −2.19% | +4.78% | −0.47% | +3.46% | −0.12% |
| +30 days | +0.34% | +11.27% | +2.49% | −10.27% | −6.61% | +2.68% | +21.51% | −8.74% | −0.40% | −6.68% | −10.43% | +8.41% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202633.00%Promoter
Promoters33.00%
FIIs9.46%0.69
DIIs16.89%2.13
Public40.55%1.46
Ownership trend
Peers
P7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,805.50 | 64.74 | 1,26,610 | 0.23% | 551 | +35.86% | 6,606 | +18.12% | 17.89% |
| Max Healthcare | ₹1,080.40 | 70.88 | 1,05,149 | 0.19% | 342 | +7.28% | 2,143 | +12.21% | 14.71% |
| Fortis Health. | ₹948.70 | 67.78 | 71,623 | 0.11% | 271 | +22.42% | 2,365 | +17.81% | 13.45% |
| Aster DM Health. | ₹785.65 | 167.78 | 68,483 | 0.64% | 154 | +41.97% | 1,182 | +18.20% | 11.40% |
| Narayana Hrudaya | ₹1,961.50 | 47.06 | 40,085 | 0.23% | 224 | +12.47% | 2,594 | +75.80% | 15.36% |
| Global Health | ₹1,371.00 | 66.15 | 36,862 | 0.04% | 142 | +4.71% | 1,159 | +24.46% | 17.14% |
| Krishna Institu. | ₹797.85 | 135.11 | 33,510 | 0.00% | 33 | −50.66% | 1,075 | +34.85% | 9.29% |
| Median: 28 Co. | ₹421.75 | 48.14 | 5,380 | 0.02% | 31 | +22.42% | 353 | +22.28% | 14.76% |
Filings
DConcall transcripts35
TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9h - Intimation for Earning Conference Call under Regulation 30 of SEBI (LODR) Regulation, 2015.Board Meeting Intimation for Schedule Of Board Meeting For The First Quarter Ended June 30, 2026, Under Regulation 29 Of Listing Regulations. 20 Jul - Board meeting on July 30, 2026 to approve Q1 FY27 unaudited financial results; trading window closedJuly 1.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jul - Regulation 74(5) certificate filed for quarter ended June 30, 2026; nil dematerialization/rematerialization.Closure of Trading Window 25 JunAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 24 Jun - Intimation under Regulation 30 of Listing Regulations regarding Allotment of Shares.